139 related articles for article (PubMed ID: 1801472)
1. [Immunosuppressor activity of B-cells in patients with chronic lymphocytic leukemia. Their possible role in the pathogenesis of the disease].
Chernykh ER; Tikhonova MA; Ostanin AA; Shevela EIa; Blazhievich IA; Shubinskiĭ GZ
Vestn Akad Med Nauk SSSR; 1991; (12):39-43. PubMed ID: 1801472
[TBL] [Abstract][Full Text] [Related]
2. [Functional properties of B-lymphocytes of patients with a B-cell variant of chronic lymphocytic leukemia and chronic glomerulonephritis].
Ostanin AA; Chernykh ER; Shubinskiĭ GZ; Nekipelova VI; Tov NL; Lozovoĭ VP
Vestn Akad Med Nauk SSSR; 1991; (12):19-23. PubMed ID: 1801468
[TBL] [Abstract][Full Text] [Related]
3. Surface markers and other characteristics of the lymphocyte in chronic lymphocytic leukemia.
Bentwich Z; Polliack A; Douglas SD
Isr J Med Sci; 1976; 12(4-5):304-22. PubMed ID: 1084879
[TBL] [Abstract][Full Text] [Related]
4. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
5. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
[TBL] [Abstract][Full Text] [Related]
6. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].
Rupniewska ZM; Wach M; Kowal M; Roliński J; Antosz H
Acta Haematol Pol; 1992; 23(1):21-7. PubMed ID: 1615748
[TBL] [Abstract][Full Text] [Related]
7. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of IgM secretion and switching to IgG production in human B leukemic cells with the help of T cells.
Saiki O; Kishimoto T; Kuritani T; Muraguchi A; Yamamura Y
J Immunol; 1980 Jun; 124(6):2609-14. PubMed ID: 6966294
[TBL] [Abstract][Full Text] [Related]
9. Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.
Yoshizaki K; Nakagawa T; Kaieda T; Muraguchi A; Yamamura Y; Kishimoto T
J Immunol; 1982 Mar; 128(3):1296-301. PubMed ID: 6799573
[TBL] [Abstract][Full Text] [Related]
10. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
11. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
12. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
13. Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia.
Eisele L; Haddad T; Sellmann L; Dührsen U; Dürig J
Leuk Res; 2009 Jun; 33(6):775-8. PubMed ID: 18922578
[TBL] [Abstract][Full Text] [Related]
14. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
[TBL] [Abstract][Full Text] [Related]
15. Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
Babusíková O; Hrivnáková A; Klobusická M; Mesárosová A; Ujházy P
Neoplasma; 1990; 37(6):693-701. PubMed ID: 2125699
[TBL] [Abstract][Full Text] [Related]
16. Chronic B-lymphocytic leukemia--expression of B cell activation markers in relation to activity of the disease.
Tötterman TH; Carlsson M; Funderud S; Simonsson B; Oberg G; Nilsson K
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):279-81. PubMed ID: 3265498
[TBL] [Abstract][Full Text] [Related]
17. Surface markers of lymphocytes and immunoglobulin alterations in chronic lymphocytic leukemia (CLL).
Aydar S; Oğüt A; Undük H; Gündüz M
New Istanbul Contrib Clin Sci; 1978 Mar; 12(2):152-60. PubMed ID: 16302701
[No Abstract] [Full Text] [Related]
18. Direct or reverse correlations within the expression of activation, differentiation or T-B cooperation molecules on chronic lymphocytic leukemia B cells.
Sellitto A; De Fanis U; Romano C; Dalla Mora L; Guastafierro S; Tirelli A; Lucivero G
Minerva Med; 2003 Oct; 94(5):331-6, 336-9. PubMed ID: 14973427
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin genes in chronic lymphocytic leukemia.
Kipps TJ
Blood Cells; 1993; 19(3):615-25; discussion 631-2. PubMed ID: 8018942
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
